Live Updates: COVID-19 Cases
  • World 21,233,606
    World
    Confirmed: 21,233,606
    Active: 6,435,434
    Recovered: 14,037,903
    Death: 760,269
  • USA 5,449,759
    USA
    Confirmed: 5,449,759
    Active: 2,424,475
    Recovered: 2,854,269
    Death: 171,015
  • Brazil 3,238,216
    Brazil
    Confirmed: 3,238,216
    Active: 775,785
    Recovered: 2,356,640
    Death: 105,791
  • India 2,525,144
    India
    Confirmed: 2,525,144
    Active: 670,764
    Recovered: 1,805,246
    Death: 49,134
  • Russia 912,823
    Russia
    Confirmed: 912,823
    Active: 174,361
    Recovered: 722,964
    Death: 15,498
  • South Africa 572,865
    South Africa
    Confirmed: 572,865
    Active: 123,978
    Recovered: 437,617
    Death: 11,270
  • Peru 507,996
    Peru
    Confirmed: 507,996
    Active: 134,342
    Recovered: 348,006
    Death: 25,648
  • Mexico 505,751
    Mexico
    Confirmed: 505,751
    Active: 108,951
    Recovered: 341,507
    Death: 55,293
  • Chile 382,111
    Chile
    Confirmed: 382,111
    Active: 16,734
    Recovered: 355,037
    Death: 10,340
  • Spain 358,843
    Spain
    Confirmed: 358,843
    Active: 330,226
    Recovered: ?
    Death: 28,617
  • Iran 338,825
    Iran
    Confirmed: 338,825
    Active: 25,683
    Recovered: 293,811
    Death: 19,331
  • UK 313,798
    UK
    Confirmed: 313,798
    Active: 272,440
    Recovered: ?
    Death: 41,358
  • Saudi Arabia 295,902
    Saudi Arabia
    Confirmed: 295,902
    Active: 29,605
    Recovered: 262,959
    Death: 3,338
  • Pakistan 287,300
    Pakistan
    Confirmed: 287,300
    Active: 15,932
    Recovered: 265,215
    Death: 6,153
  • Bangladesh 271,881
    Bangladesh
    Confirmed: 271,881
    Active: 111,667
    Recovered: 156,623
    Death: 3,591
  • Italy 252,809
    Italy
    Confirmed: 252,809
    Active: 14,249
    Recovered: 203,326
    Death: 35,234
  • Turkey 246,861
    Turkey
    Confirmed: 246,861
    Active: 11,947
    Recovered: 228,980
    Death: 5,934
  • Germany 222,880
    Germany
    Confirmed: 222,880
    Active: 12,795
    Recovered: 200,800
    Death: 9,285
  • France 212,211
    France
    Confirmed: 212,211
    Active: 98,333
    Recovered: 83,472
    Death: 30,406
  • Canada 121,414
    Canada
    Confirmed: 121,414
    Active: 4,602
    Recovered: 107,793
    Death: 9,019
  • China 84,786
    China
    Confirmed: 84,786
    Active: 690
    Recovered: 79,462
    Death: 4,634
  • Netherlands 61,840
    Netherlands
    Confirmed: 61,840
    Active: 55,673
    Recovered: ?
    Death: 6,167
  • Australia 22,743
    Australia
    Confirmed: 22,743
    Active: 9,018
    Recovered: 13,350
    Death: 375
  • S. Korea 14,873
    S. Korea
    Confirmed: 14,873
    Active: 705
    Recovered: 13,863
    Death: 305
  • New Zealand 1,602
    New Zealand
    Confirmed: 1,602
    Active: 49
    Recovered: 1,531
    Death: 22

Herd immunity in India may generate only in pockets, can be short-lived: scientists

Author at TechGenyz Health
Herd Immunity
A photo of a man trying to say to stop COVID-19 credit: @fernando zhiminaicela |Pixabay

Herd immunity against COVID-19 in India is likely to be achieved only in pockets given the many socio-economic groups in the country and maybe short-lived rather than long-lasting, say scientists as sero surveillance data from New Delhi and Mumbai raise hopes of community protection’ from the disease.

Herd immunity occurs when a large number of people, usually 70 to 90 per cent, become immune to a contagious disease after being infected to it.

But there are many grey areas clouding the issue as far as the novel coronavirus is concerned with no consensus on when herd immunity sets in.

There are no clear numbers to say at what per cent of the infected population we will achieve herd immunity. Many epidemiologists believe that for SARS-CoV-2 it would be at around 60 per cent, said Shahid Jameel, virologist and CEO of the Wellcome Trust/DBT India Alliance, a public charity that invests in building biomedical sciences and health research frameworks.

He said different parts of the country will get closer to herd immunity at different times.

A recent study published in the journal Science also found that herd immunity against COVID-19 could be achieved with fewer people being infected than previously estimated.

Herd immunity is determined primarily by how many individuals in a population are immune to a particular infection. This results in indirect immunity to others in the population who never got exposed or infected explained virologist Upasana Ray.

Essentially, herd immunity means that the more the number of people get infected and develop immunity, the less chance there is for others in the population to get infected, Ray, senior scientist at CSIR-IICB, Kolkata, told PTI.

Immunologist Satyajit Rath agreed that it was not known at what point of the infection herd immunity would set in.

In India, with its multitude of socio-economic groupings, herd immunity may be generated in pockets rather than uniformly across the country, and may be short-lived, Rath, from New Delhi’s National Institute of Immunology, told PTI.

And therefore, the idea of naturally generated long-lasting herd immunity may not be of much practical policy relevance for India, he added.

The debate on herd immunity intensified following sero-surveys from New Delhi and Mumbai, two of India’s most populated cities where the number of COVID-19 cases surged before showing a declining trend.

The sero-surveillance study in Mumbai revealed that 57 per cent of its slum population and 16 per cent of its non-slum residents in three civic wards had developed antibodies, indicating many people would already be affected by COVID-19 than the official tally suggests.

These results will be valuable to learn more about herd immunity,” stated Brihanmumbai Municipal Corporation (BMC) in a statement.

Delhi’s sero-survey showed that nearly 23 per cent of the people had exposure to the novel coronavirus, which has infected over 1.5 million people in the country and killed nearly 35,000.

Sero-surveillance provides estimates of antibody levels against infectious diseases and is considered the gold standard for measuring population immunity due to past infection or vaccination.

An antibody is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralise pathogens like viruses.

Rath noted that seropositivity does not necessarily indicate protective immunity, adding that there is some evidence the antibody responses may be short-lived, in which case many people may soon become ‘susceptible’ again.

On the other hand, he said, infected people also develop T cell immune responses which are not being measured in such surveys.

T cells — that play a central role in the immune response — might be somewhat longer-lasting, but it is not known what their relationship with protection is.

So while my guess is that, broadly, once we get infected we are likely to be somewhat immune, at least for a few months, against re-infection, I think there are many unknowns and caveats and we should not be jumping to easy conclusions, Rath added.

Virologist Jameel said it would be a mistake to talk of herd immunity on a national scale.

This is because conditions such as population density, virus prevalence and transmission of infection vary across the country and even within a state of a metro city, Jameel told PTI.

For example, one cannot compare Mumbai city to Arunachal Pradesh. Even in Mumbai, one cannot compare a densely populated area such as Dharavi to South Mumbai. Herd immunity is best understood in terms of a community, locality or population group, he explained.

Herd immunity, Ray added, also depends on how Infectious the pathogen is. So, if a virus is extremely infectious and less pathogenic, herd immunity will be achieved faster, she said.

Pathogenicity is the capacity of a virus to cause damage in a host, while infectivity is the ability of a pathogen to establish an infection.

So, the more the pathogenicity, the more time it will take for herd immunity. More the infectivity, and if it’s moderate to less pathogenic, the faster shall we achieve herd immunity, Ray said.

A Spanish study published in The Lancet journal in the first week of July cast doubts over the feasibility of herd immunity as a way of tackling the pandemic.

The study of over 60,000 people estimated that around just five per cent of the Spanish population has developed antibodies.

Depending upon what model you believe in, we may or may not be close to herd immunity. Another factor to consider is that people are always moving about in and out of various zones or areas and between states, Jameel said.

Career

Subscribe